Access Bio company has scheduled its next shareholders meeting for 25 Mar'21 (as Sth Korea FY runs Jan-Dec period)
Due to Sth Korea financial disclosure requirements - as the company has made than 30% of sales or profit and loss structure already - its had to release consolidated $ statement - before the shareholder's meeting....which is very interesting reading
9 Feb'21 - Consolidated statement
http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210209900437Copy of the finance table within - amts in US$
Almost all of this extra profit rev is from those rapid fire Access Bio Ag test sales orders (since Sept'20)...and this statement does not include the US$70m ordered in Jan'21...so they are well on their way already to potentially exceeding this total for FY21/CY21 period...
AT1 FY21 - General Discussion + FA, page-762
-
- There are more pages in this discussion • 1,672 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $12.14M | |||
| Open | High | Low | Value | Volume |
| 2.0¢ | 2.1¢ | 1.9¢ | $3.016K | 150.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 628443 | 1.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.1¢ | 291292 | 2 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| AT1 (ASX) Chart |